Apple Partners with Klarna for New “Apple Upgrade” Device Leasing Program
The program covers most iPhones, Macs, iPads, and Apple Watches.
Already have an account? Sign in.
The program covers most iPhones, Macs, iPads, and Apple Watches.
Axogen will use proceeds from a $208.7 million stock offering to buy BioCircuit Technologies and its NerveTape device, the first FDA-cleared sutureless option for peripheral nerve repair.
The FDA has paused new patient enrollment in Biohaven’s BHV-7000 epilepsy studies after rodent findings. Dosing continues for current participants.
Officials weigh higher factory costs against U.S. mining goals. Copper prices hit records as buyers stockpile ahead of a possible tariff.